Non-invasive Brain Stimulation for Treating Symptomatic Convergence Insufficiency

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Convergence Insufficiency
Interventions
DEVICE

Anodal-Transcranial Direct Current Stimulation

Non-invasive brain stimulation will involve the use of anodal transcranial direct current stimulation to apply a 2 milliamp current over the left frontal eye field for approximately 20 minutes with a ramp up to the maximum programmed current and ramp down of 20 seconds.

BEHAVIORAL

Office-Based Vergence/Accommodative Therapy

Office-based vergence accommodative therapy involves weekly in-office appointments with the therapist lasting approximately 60 minutes per visit during which time in-office procedures will be performed, and home therapy procedures will be demonstrated. Participants will be prescribed 15 minutes of home reinforcement therapy procedures to be completed 5 days per week. Therapy will consist of two phases adapted from the Convergence Insufficiency Treatment Trial (CITT). Therapy procedures will include gross convergence, accommodation. non-computer based vergence, and computer-based vergence.

DEVICE

Sham Transcranial Direct Current Stimulation

Sham transcranial direct current stimulation will be applied over the left frontal eye field with the current ramping up for 20 seconds before ramping down for 20 seconds. The 2 milliamp current stimulation will occur for only a few seconds at the start and at the end of the 20 minutes.

Trial Locations (1)

60515

RECRUITING

Midwestern University Eye Institute, Downers Grove

All Listed Sponsors
lead

Midwestern University

OTHER